Correlation Between Woori Financial and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Woori Financial and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Woori Financial and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Woori Financial Group and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Woori Financial and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Woori Financial with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Woori Financial and Catalyst Pharmaceuticals.
Diversification Opportunities for Woori Financial and Catalyst Pharmaceuticals
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Woori and Catalyst is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Woori Financial Group and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Woori Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Woori Financial Group are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Woori Financial i.e., Woori Financial and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Woori Financial and Catalyst Pharmaceuticals
Allowing for the 90-day total investment horizon Woori Financial Group is expected to generate 1.19 times more return on investment than Catalyst Pharmaceuticals. However, Woori Financial is 1.19 times more volatile than Catalyst Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 3,772 in Woori Financial Group on May 4, 2025 and sell it today you would earn a total of 1,371 from holding Woori Financial Group or generate 36.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Woori Financial Group vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Woori Financial Group |
Catalyst Pharmaceuticals |
Woori Financial and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Woori Financial and Catalyst Pharmaceuticals
The main advantage of trading using opposite Woori Financial and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Woori Financial position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Woori Financial vs. Shinhan Financial Group | Woori Financial vs. KB Financial Group | Woori Financial vs. Banco De Chile | Woori Financial vs. Orix Corp Ads |
Catalyst Pharmaceuticals vs. Amylyx Pharmaceuticals | Catalyst Pharmaceuticals vs. Axsome Therapeutics | Catalyst Pharmaceuticals vs. Exelixis | Catalyst Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |